z-logo
open-access-imgOpen Access
CpG Inhibits Pro-B Cell Expansion through a Cathepsin B-Dependent Mechanism
Author(s) -
Ana I. Lalanne,
Ignacio Moraga,
Yi Hao,
João P. Pereira,
Nuno L. Alves,
Nicholas D. Huntington,
António A. Freitas,
Ana Cumano,
Paulo Vieira
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.0903854
Subject(s) - tlr9 , lymphopoiesis , microbiology and biotechnology , b cell , cathepsin b , biology , cpg site , progenitor cell , chemistry , immunology , stem cell , gene , gene expression , antibody , biochemistry , enzyme , dna methylation
TLR9 is expressed in cells of the innate immune system, as well as in B lymphocytes and their progenitors. We investigated the effect of the TLR9 ligand CpG DNA on the proliferation of pro-B cells. CpG DNA inhibits the proliferation of pro-B, but not pre-B, cells by inducing caspase-independent cell death through a pathway that requires the expression of cathepsin B. This pathway is operative in Rag-deficient mice carrying an SP6 transgene, in which B lymphopoiesis is compromised, to reduce the size of the B lymphocyte precursor compartments in the bone marrow. Thus, TLR9 signals can regulate B lymphopoiesis in vivo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom